These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 19273790

  • 41. Technetium-99 conjugated with methylene diphosphonate (99Tc-MDP) inhibits experimental choroidal neovascularization in vivo and VEGF-induced cell migration and tube formation in vitro.
    Lai K, Xu L, Jin C, Wu K, Tian Z, Huang C, Zhong X, Ye H.
    Invest Ophthalmol Vis Sci; 2011 Jul 29; 52(8):5702-12. PubMed ID: 21666238
    [Abstract] [Full Text] [Related]

  • 42. Effects of epoxyeicosatrienoic acids (EETs) on retinal macular degeneration in rat models.
    Mei F, Wang JG, Chen ZJ, Yuan ZL.
    Eur Rev Med Pharmacol Sci; 2017 Jun 29; 21(12):2970-2979. PubMed ID: 28682418
    [Abstract] [Full Text] [Related]

  • 43. Comparing pegaptanib and triamcinolone efficacy in the rat choroidal neovascularization model.
    Criswell MH, Hu WZ, Steffens TJ, Li R, Margaron P.
    Arch Ophthalmol; 2008 Jul 29; 126(7):946-52. PubMed ID: 18625941
    [Abstract] [Full Text] [Related]

  • 44. Suppression of laser-induced choroidal neovascularization by posterior sub-tenon administration of triamcinolone acetonide.
    Kato A, Kimura H, Okabe K, Okabe J, Kunou N, Nozaki M, Ogura Y.
    Retina; 2005 Jun 29; 25(4):503-9. PubMed ID: 15933599
    [Abstract] [Full Text] [Related]

  • 45. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model.
    Ciulla TA, Criswell MH, Danis RP, Hill TE.
    Arch Ophthalmol; 2001 Mar 29; 119(3):399-404. PubMed ID: 11231773
    [Abstract] [Full Text] [Related]

  • 46. Triptolide attenuates laser-induced choroidal neovascularization via M2 macrophage in a mouse model.
    Lai K, Gong Y, Zhao W, Li L, Huang C, Xu F, Zhong X, Jin C.
    Biomed Pharmacother; 2020 Sep 29; 129():110312. PubMed ID: 32559620
    [Abstract] [Full Text] [Related]

  • 47. Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization.
    Yoshikawa N, Noda K, Ozawa Y, Tsubota K, Mashima Y, Ishida S.
    Mol Vis; 2012 Sep 29; 18():593-600. PubMed ID: 22419852
    [Abstract] [Full Text] [Related]

  • 48. Expression of hypoxia-inducible factor-1alpha and -2alpha in human choroidal neovascular membranes.
    Sheridan CM, Pate S, Hiscott P, Wong D, Pattwell DM, Kent D.
    Graefes Arch Clin Exp Ophthalmol; 2009 Oct 29; 247(10):1361-7. PubMed ID: 19590888
    [Abstract] [Full Text] [Related]

  • 49. Differential expression of vascular endothelial growth factor-a isoforms in neovascular age-related macular degeneration.
    Grisanti S, Zhu Q, Tatar O, Lueke J, Lueke M, Tura A, Grisanti S.
    Retina; 2015 Apr 29; 35(4):764-72. PubMed ID: 25494018
    [Abstract] [Full Text] [Related]

  • 50. Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy.
    Bottoni F, Romano M, Massacesi A, Bergamini F.
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov 29; 244(11):1528-33. PubMed ID: 16609904
    [Abstract] [Full Text] [Related]

  • 51. Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration.
    Penfold PL, Wong JG, Gyory J, Billson FA.
    Clin Exp Ophthalmol; 2001 Jun 29; 29(3):188-92. PubMed ID: 11446466
    [Abstract] [Full Text] [Related]

  • 52. VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV.
    Huang H, Parlier R, Shen JK, Lutty GA, Vinores SA.
    PLoS One; 2013 Jun 29; 8(8):e71808. PubMed ID: 23977149
    [Abstract] [Full Text] [Related]

  • 53. Triamcinolone acetonide suppresses early proangiogenic response in retinal pigment epithelial cells after photodynamic therapy in vitro.
    Obata R, Iriyama A, Inoue Y, Takahashi H, Tamaki Y, Yanagi Y.
    Br J Ophthalmol; 2007 Jan 29; 91(1):100-4. PubMed ID: 16987905
    [Abstract] [Full Text] [Related]

  • 54. Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor.
    Jin J, Zhou KK, Park K, Hu Y, Xu X, Zheng Z, Tyagi P, Kompella UB, Ma JX.
    Invest Ophthalmol Vis Sci; 2011 Aug 05; 52(9):6230-7. PubMed ID: 21357401
    [Abstract] [Full Text] [Related]

  • 55. Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration.
    Gopal L, Sharma T.
    Indian J Ophthalmol; 2007 Aug 05; 55(6):431-5. PubMed ID: 17951899
    [Abstract] [Full Text] [Related]

  • 56. Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells.
    Kambhampati SP, Mishra MK, Mastorakos P, Oh Y, Lutty GA, Kannan RM.
    Eur J Pharm Biopharm; 2015 Sep 05; 95(Pt B):239-49. PubMed ID: 25701805
    [Abstract] [Full Text] [Related]

  • 57. Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization.
    Dong Z, Noda K, Kanda A, Fukuhara J, Ando R, Murata M, Saito W, Hagiwara M, Ishida S.
    Mol Vis; 2013 Sep 05; 19():536-43. PubMed ID: 23559848
    [Abstract] [Full Text] [Related]

  • 58. Inhibition of ocular neovascularization by co-inhibition of VEGF-A and PLGF.
    Huo X, Li Y, Jiang Y, Sun X, Gu L, Guo W, Sun D.
    Cell Physiol Biochem; 2015 Sep 05; 35(5):1787-96. PubMed ID: 25832861
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.